Forbion European Acquisition 10-Q 13 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Registrant Name	FORBION EUROPEAN ACQUISITION CORP.
Entity Central Index Key	0001874495
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	4001 Kennett Pike
Entity Address, Address Line Two	Suite 302
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19807
City Area Code	302
Local Phone Number	273 0765
Entity File Number	001-41148
Entity Tax Identification Number	00-0000000
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	FRBN
Security Exchange Name	NASDAQ
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
Trading Symbol	FRBNU
Security Exchange Name	NASDAQ
Redeemable Warrants [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	FRBNW
Security Exchange Name	NASDAQ
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		12,650,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		3,162,500

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 909,562	$ 1,069,298
Prepaid expense	520,948	498,591
Total current assets	1,430,510	1,567,889
Prepaid expenses – non-current portion	97,060	209,052
Cash and securities held in trust account	129,710,862	129,669,409
Total assets	131,238,432	131,446,350
Current liabilities:
Accrued offering costs and expenses	463,772	316,651
Due to related party	59,289	10,796
Total current liabilities	523,061	327,447
Deferred underwriting commissions	3,727,500	3,727,500
Total liabilities	4,250,561	4,054,947
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, 12,650,000 shares at redemption value of $10.25 at March 31, 2022 and December 31, 2021	129,710,862	129,669,409
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(2,723,307)	(2,278,322)
Total shareholders' deficit	(2,722,991)	(2,278,006)
Total Liabilities, Shares Subject to Redemption and Shareholders' Deficit	131,238,432	131,446,350
Common Class A [Member]
Shareholders' Deficit:
Common stock	0	0
Common Class B [Member]
Shareholders' Deficit:
Common stock	$ 316	$ 316

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity, shares outstanding	12,650,000	12,650,000
Temporary equity, redemption price per share	$ 10.25	$ 10.25
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common stock, Shares, Outstanding	0	0
Common Class B [Member]
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	3,162,500	3,162,500
Common stock, Shares, Outstanding	3,162,500	3,162,500

Condensed Statement Of Operatio

Condensed Statement Of Operations	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Operating Costs	$ 445,019
Loss from operations	(445,019)
Other income
Interest earned from Trust Account	41,453
Bank interest income	34
Total other income	41,487
Net loss	$ (403,532)
Common Class A [Member]
Other income
Basic and diluted weighted average shares outstanding | shares	12,650,000
Basic and diluted net income (loss) per share | $ / shares	$ (0.03)
Common Class B [Member]
Other income
Basic and diluted weighted average shares outstanding | shares	3,162,500
Basic and diluted net income (loss) per share | $ / shares	$ (0.03)

Condensed Statement Of Changes

Condensed Statement Of Changes In Shareholder's Deficit - 3 months ended Mar. 31, 2022 - USD ($)	Total	Common Stock [Member]Common Class A [Member]	Common Stock [Member]Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2021	$ (2,278,006)	$ 0	$ 316	$ 0	$ (2,278,322)
Balance, shares at Dec. 31, 2021		0	3,162,500
Re-measurement of Class A common stock subject to possible redemption to redemption amount	(41,453)				(41,453)
Net loss	(403,532)				(403,532)
Balance at Mar. 31, 2022	$ (2,722,991)	$ 0	$ 316	$ 0	$ (2,723,307)
Balance, shares at Mar. 31, 2022		0	3,162,500

Condensed Statement Of Cash Flo

Condensed Statement Of Cash Flows	3 Months Ended
	Mar. 31, 2022USD ($)
Cash flows from operating activities:
Net loss	$ (403,532)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(41,453)
Changes in operating assets and liabilities:
Prepaid expenses	89,635
Accrued offering costs and expenses	147,121
Due from related party	48,493
Net cash used in operating activities	(159,736)
Net change in cash	(159,736)
Cash, beginning of the period	1,069,298
Cash, end of the period	$ 909,562

Organization, Business Operatio

Organization, Business Operation and Liquidity	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Business Operation and Liquidity	Note 1 — Organization, Business Operation and Liquidity Forbion European Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on August 9, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or entities (the “Business Combination”). As of March 31, 2022, the Company had not commenced any operations. All activity through March 31, 2022 relates to the Company’s formation and the Initial Public Offering (“IPO”) which is described below, and the Company’s completion of a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income The Company’s Sponsor is Forbion Growth Sponsor FEAC I B.V., a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s the IPO was declared effective on December 9, 2021 (the “Effective Date”). On December 14, 2021, the Company’s commenced the IPO of 11,000,000 units (or 12,650,000 units if the underwriters’ over-allotment option is exercised in full) at $10.00 per unit (the “Units”), which is discussed in Note 3. Each Unit consists of one Class A ordinary share and one-third of Simultaneously with the consummation of the IPO, the Company consummated the private placement of 4,700,000 warrants (or 5,195,000 warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021) (the “Private Placement Warrants”) to the Sponsor, at a price of $1.50 per Private Placement Warrant in a private placement. The sale of the Private Placement warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500. Transaction costs related to the IPO amounted to $5,793,160 consisting of $1,800,000 of underwriting commissions, $3,150,000 of deferred underwriting commissions, and $843,160 of other offering costs. The underwriters’ exercise of their full over-allotment option generated an additional $907,500 in transaction costs for aggregate transaction costs of $6,700,660 consisting of $2,130,000 of underwriting commissions, $3,727,500 of deferred underwriting commissions and $843,160 of other offering costs. In addition, $1,641,236 of cash was held outside of the Trust Account (as defined below) and is available for working capital purposes. On December 15, 2021, the underwriter fully exercised the over-allotment option and purchased an additional 1,650,000 Units for additional gross proceeds of $16,500,000. Simultaneously with the exercise of the over-allotment option, the Sponsor purchased an addition 495,000 Private Placement Warrants for additional gross proceeds of $742,500, which was already included in the Trust Account and shown as a Deposit in Advance in this financial statement. The underwriters’ exercise of their full over-allotment option generated an additional $907,500 in transaction costs for aggregate transaction costs of $6,700,660 consisting of $2,130,000 of underwriting commissions, $3,727,500 of deferred underwriting commissions and $843,160 of other offering costs. Following the closing of the exercise of the underwriters’ full over-allotment option, an additional $16,170,000 was placed in the Trust Account for aggregate proceeds in the Trust Account of $129,662,500 ($10.25 per Unit). As a result of the underwriters’ over-allotment option exercise, 412,500 Founder Shares are no longer subject to forfeiture. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of signing a definitive agreement in connection with the initial Business Combination. However, the Company will complete the initial Business Combination only if the post-Business Combination company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or is otherwise not required to register as an investment company under the Investment Company Act (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in additional to a $742,500 Deposit in Advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was held in the Trust Account and will only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under -up capital for The Company will provide holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the IPO (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirement. The Company will provide its public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of the initial Business Combination, regardless of whether such shareholder votes on such proposed Business Combination, and if they do vote, regardless of whether they vote for or against such proposed Business Combination, at a per-share price, payable in The per share amount The Company will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be no redemption rights upon the completion of the initial Business Combination with respect to the Company’s warrants. Further, the Company will not proceed with redeeming the public shares, even if a public shareholder has properly elected to redeem its shares if a Business Combination does not close. The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company’s amended and restated memorandum and articles of association provides that the Company will have only 18 months from the closing of the Public Offering (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination, subject to the Sponsor depositing additional funds in the Trust Account) (the “Combination Period”) to consummate its initial Business Combination. If the Company has not consummated an initial Business Combination within Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable The Sponsor and each member of its management team have entered into an agreement with Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their Founder Shares (ii) to waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within Combination Period or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to consummate an initial Business Combination within Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame). The Company has until 18 months from the closing of the Public Offering to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within 18 months, the Company may extend the period of time to consummate a Business Combination by up to two additional three-month periods (for a total of 24 months to complete a Business Combination (the “Combination Period”). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the Trust Account, for each additional three-month period, $1,265,000 ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.25 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriter of the Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations. Liquidity, Capital Resources and Going Concern The Company’s liquidity needs up to December 14, 2021 had been satisfied through a payment from the Sponsor of $25,000 (see Note 5) for the Founder Shares to cover certain offering costs and the loan under an unsecured promissory note from the Sponsor of up to $500,000. At March 31, 2022, the Company had $909,562 in its operating bank account and working capital of approximately $907,449, which mainly consisted of the portion of proceeds of the sale of the Private Placement Warrants not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC 205-40, Presentation of Financial Statements—Going Concern”, management has determined that the Company has and will continue to incur significant costs in pursuit of its acquisition plans which raises substantial doubt about the Company’s ability to continue as a going concern. Moreover, we may need to obtain additional financing either to complete our initial Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Accounts. In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. Further, management has determined that if the Company is unable to complete a Business Combination by June 14, 2023 (the “Combination Period”), then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution as well as the Company’s working capital deficit raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period. The Company intends to complete a Business Combination before the mandatory liquidation date. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic,

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and in accordance with the instructions on Form 10-Q S-X necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s should be read in conjunction with the Company’s unaudited condensed financial statements and notes thereto included in the Form 10-K Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart O Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and non-financial assets are re-measured and The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Cash and Securities Held in Trust Account As of March 31, 2022, investment in the Company’s Trust Account consisted of $1,485 in cash and $129,709,377 in U.S. Treasury Securities. As of December 31, 2021, investment in the Company’s Trust Account consisted of $1,485 cash and $129,667,924 in U.S. Treasury Securities. All of the U.S. Treasury Securities will mature on June 16, 2022. The Company classified its U.S. Treasury Securities as held-to-maturity Held-to-maturity Held-to-maturity Carrying Value as of March 31, 2022 Quoted Prices in Active Markets (Level 1) Gross Unrealized (Losses) U.S. Treasury Securities $ 129,709,377 $ 129,630,124 $ (79,253 ) Cash 1,485 1,485 — $ 129,710,862 $ 129,631,608 $ (79,253 ) Carrying Value as of December 31, Quoted Prices in Active Markets (Level 1) Gross Unrealized Losses U.S. Treasury Securities $ 129,667,924 $ 129,665,154 $ (2,770 ) Cash 1,485 — — $ 129,669,409 $ 129,665,154 $ (2,770 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 12,650,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. The Class A ordinary shares subject to possible redemption reflected on the balance sheet as of March 31, 2022 and December 31, 2021 is reconciled in the following table: Gross Proceeds from IPO $ 129,662,500 Less: Proceeds allocated to Public Warrants (3,493,159 ) Class A ordinary shares issuance costs (9,678,128 ) Plus: Remeasurement of carrying value to redemption value 13,178,196 Interest income 41,453 Class A ordinary shares subject to possible redemption $ 129,710,862 Offering Costs associated with the Initial Public Offering Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. and non-redeemable shares they Net Loss Per Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The statement of operations include a presentation of income (loss) per Class A ordinary share and income (loss) per Class B ordinary share following the two-class method For the three months ended March 31, 2022 Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (322,826 ) $ (80,706 ) Denominator: Weighted-average shares outstanding including ordinary shares subject to redemption 12,650,000 3,162,500 Basic and diluted net loss per share $ (0.03 ) $ (0.03 ) Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) (Subtopic 815-40) (“ASU 2020-06”) to simplify 2020-06 2020-06 if-converted 2020-06 Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering On December 14, 2021, the Company consummated its IPO of 11,000,000 Units at a purchase price of $10.00 per Unit. Each Unit that the Company is offering has a price of $10.00 and consists of one Class A ordinary share and one-third Following the closing of the IPO on December 14, 2021, $113,492,500 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into a trust account (the “Trust Account”). This amount was comprised of $10.25 per Unit for the 11,000,000 Units sold in the IPO in additional to a $742,500 Deposit in Advance from the Sponsor related to the underwriters’ exercise of the full over-allotment option which took place the following day on December 15, 2021. Following the closing of the IPO and the exercise of the underwriters’ full over-allotment option, $129,662,500 ($10.25 per Unit) was placed in a Trust Account and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under

Private Placement

Private Placement	3 Months Ended
	Mar. 31, 2022
Private Placement [Abstract]
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the IPO, the Company’s Sponsor purchased an aggregate of 4,700,000 Private Placement Warrants (5,195,000 Private Placement Warrants when the underwriters’ over-allotment option was fully exercised on December 15, 2021), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Unit. The sale of the Private Placement warrants in connection with the IPO and subsequent over-allotment option exercise generated gross proceeds of $7,792,500. The Private Placement Warrants are not be transferable, assignable or salable (and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants are not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination), except as described herein under “Principal Shareholders — Transfers of Founder Shares and Private Placement Warrants.” If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants are redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the Units sold in the Public Offering. Any amendment to the terms of the Private Placement Warrants or any provision of the warrant agreement with respect to the Private Placement Warrants require a vote of holders of at least 50% of the number of the then outstanding Private Placement Warrants.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On August 12, 2021, Forbion European Sponsor LLP paid $25,000, or approximately $0.009 per share, to cover certain offering costs in consideration for 2,875,000 Class B ordinary shares (the “Founder Shares”), par value $0.0001. On November 23, 2021, Forbion European Sponsor LLP transferred 2,875,000 Class B ordinary shares to the Sponsor in exchange for $25,000, or approximately $0.009 per share. On December 9, 2021, the Company issued 287,500 Class B ordinary shares to the Sponsor resulting from a 1.1 for 1 share dividend. Up to 412,500 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. On December 15, 2021, the underwriters fully exercised their over-allotment and as a result, 412,500 Founder Shares are no longer subject to forfeiture. Promissory Note — Related Party On August 12, 2021, Forbion European Sponsor LLP agreed to loan the Company up to $500,000 to be used for a portion of the expenses of the Public Offering. These loans are non-interest bearing, Working Capital Loans In order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close. The Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans. Related Party Extension Loans The Company may extend the period of time to consummate a Business Combination by up to two additional three-month periods (for a total of 24 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the trust account, for each additional three-month period, $1,265,000, ($0.10 per Public Share in either case), on or prior to the date of the applicable deadline. Any such payments would be made in the form of a non- interest bearing, unsecured promissory note. Such notes would either be paid upon consummation of a Business Combination, or, at the relevant insider’s discretion, converted upon consummation of a Business Combination into additional Private Placement Warrants at a price of $1.50 per Private Warrant. The Sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for the Company to complete a Business Combination. Office Space, Secretarial and Administrative Services Commencing on the date that the Company’s securities are first listed on the NASDAQ through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support and to reimburse the Sponsor for any out-of-pocket expenses Additionally, the Sponsor has agreed to pay an annual salary of $25,000 to each of the independent Board Members for services rendered prior to or in connection with the completion of the Business Combination. Board members are entitled to reimbursement for any out-of-pocket expenses respectively, in compensation expense to the independent board members which are included in due to related party on balance sheets.

Commitments & Contingencies

Commitments & Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 6 — Commitments & Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans and extension loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and extension loans) will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of the Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. However, the registration and shareholder rights agreement provide s Except as described herein, the Sponsor and the Company’s directors and executive officers have agreed not to transfer, assign or sell (i) their Founder Shares until the earliest of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, days within any 30-trading herein as the lock-up. In addition, pursuant to the registration and shareholder rights agreement, the Sponsor, upon and following consummation of an initial Business Combination, will be entitled to nominate three individuals for appointment to the Company’s board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement. Prior to the Business Combination, only holders of Class B ordinary shares will be able to vote on the appointment of directors and to continue the Company in a jurisdiction outside the Cayman Islands. Underwriting Agreement The underwriters had a 45-day option from The underwriters were paid underwriting commission of $0.20 per Unit sold in the IPO, excluding Units sold to Forbion Cooperatief, or $1,800,000, upon the closing of the IPO. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $330,000 for an aggregate of $2,130,000 in underwriting commissions related to the IPO and over-allotment. In addition, $3,150,000 is payable to the underwriters for deferred underwriting commissions related to the Units sold in the IPO, excluding those Units sold to Forbion Cooperatief. Following the exercise of the underwriters’ over-allotment option on December 15, 2021, the underwriters earned an additional $577,500 for an aggregate of $3,727,500 in deferred underwriting commissions related to the IPO and over-allotment. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreements The Company has entered into two forward purchase agreements with an affiliate of the Sponsor (the “FPA Purchaser”), pursuant to which the FPA Purchaser has agreed to purchase (1) an aggregate of 1,000,000 Class A ordinary shares for $10.00 per share (the “firm forward purchase shares”), or an aggregate amount of $10,000,000 and (2) in addition, an aggregate of up to 1,000,000 Class A ordinary shares for $10.00 per share (the “additional forward purchase shares”), or an aggregate maximum amount of up to $10,000,000, in each case in a private placement that may close simultaneously with the closing of the Company’s initial Business Combination. Deferred Legal Fees The Company has incurred $125,000 in legal fees associated with the Company’s Initial Public Offering. These fees are deferred and will become payable upon the consummation of the Business Combination and are included in accrued offering costs and expenses on the Company’s balance sheets.

Shareholders' Deficit

Shareholders' Deficit	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Shareholders' Deficit	Note 7 — Shareholders’ Deficit Preference shares Class A ordinary shares Class B ordinary shares aggregate of 3,162,500 Founder Shares outstanding, of which 412,500 are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part. All share and per share amounts have been retroactively restated to reflect the share dividend. The forfeiture amounts were determined such that the initial shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the Public Offering. At March 31, 2022 and December 31, 2021, there were 3,162,500 shares of class B ordinary shares issued and outstanding. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by the Company’s shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of the Company’s The Class B ordinary shares and will automatically convert into Class A ordinary shares, which such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions if t aggregate, on an as-converted of less than one-to-one. Public Warrants The warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than twenty blue-sky Redemption of public warrants • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption, which the Company refer to as the “30-day • if, and only if, the last reported sale price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Redemption Procedures — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading The Company will not redeem the w throughout the 30-day redemption period. If The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Redemption Procedures — Anti-dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. If the Company calls the Public Warrants for redemption as described above, it will have the option to require any holder that wishes to exercise its public warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their public warrants on a “cashless basis,” the Company will consider, among other factors, its cash position, the number of public warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of Class A ordinary shares issuable upon the exercise of the Public Warrants. If the Company takes advantage of this option, all holders of Public Warrants would pay the exercise price by surrendering their public warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the 10-day average closing No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if the Company is not the surviving company in the Business Combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were issued. Based on this, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and in accordance with the instructions on Form 10-Q S-X necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s should be read in conjunction with the Company’s unaudited condensed financial statements and notes thereto included in the Form 10-K
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart O Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and non-financial assets are re-measured and The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
Cash and Securities Held in Trust Account	Cash and Securities Held in Trust Account As of March 31, 2022, investment in the Company’s Trust Account consisted of $1,485 in cash and $129,709,377 in U.S. Treasury Securities. As of December 31, 2021, investment in the Company’s Trust Account consisted of $1,485 cash and $129,667,924 in U.S. Treasury Securities. All of the U.S. Treasury Securities will mature on June 16, 2022. The Company classified its U.S. Treasury Securities as held-to-maturity Held-to-maturity Held-to-maturity Carrying Value as of March 31, 2022 Quoted Prices in Active Markets (Level 1) Gross Unrealized (Losses) U.S. Treasury Securities $ 129,709,377 $ 129,630,124 $ (79,253 ) Cash 1,485 1,485 — $ 129,710,862 $ 129,631,608 $ (79,253 ) Carrying Value as of December 31, Quoted Prices in Active Markets (Level 1) Gross Unrealized Losses U.S. Treasury Securities $ 129,667,924 $ 129,665,154 $ (2,770 ) Cash 1,485 — — $ 129,669,409 $ 129,665,154 $ (2,770 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts.
Ordinary Shares Subject to Possible Redemption	Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 12,650,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit. The Class A ordinary shares subject to possible redemption reflected on the balance sheet as of March 31, 2022 and December 31, 2021 is reconciled in the following table: Gross Proceeds from IPO $ 129,662,500 Less: Proceeds allocated to Public Warrants (3,493,159 ) Class A ordinary shares issuance costs (9,678,128 ) Plus: Remeasurement of carrying value to redemption value 13,178,196 Interest income 41,453 Class A ordinary shares subject to possible redemption $ 129,710,862
Offering Costs associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. The Company complies with the requirements of the ASC 340-10-S99-1. and non-redeemable shares they
Net Loss Per Share	Net Loss Per Share The Company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” The statement of operations include a presentation of income (loss) per Class A ordinary share and income (loss) per Class B ordinary share following the two-class method For the three months ended March 31, 2022 Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (322,826 ) $ (80,706 ) Denominator: Weighted-average shares outstanding including ordinary shares subject to redemption 12,650,000 3,162,500 Basic and diluted net loss per share $ (0.03 ) $ (0.03 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, 470-20) (Subtopic 815-40) (“ASU 2020-06”) to simplify 2020-06 2020-06 if-converted 2020-06 Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Debt Securities, Held-to-maturity	The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities at March 31, 2022 and December 31, 2021 are as follows: Carrying Value as of March 31, 2022 Quoted Prices in Active Markets (Level 1) Gross Unrealized (Losses) U.S. Treasury Securities $ 129,709,377 $ 129,630,124 $ (79,253 ) Cash 1,485 1,485 — $ 129,710,862 $ 129,631,608 $ (79,253 ) Carrying Value as of December 31, Quoted Prices in Active Markets (Level 1) Gross Unrealized Losses U.S. Treasury Securities $ 129,667,924 $ 129,665,154 $ (2,770 ) Cash 1,485 — — $ 129,669,409 $ 129,665,154 $ (2,770 )
Summary of Class A Ordinary Shares Subject to possible Redemption	The Class A ordinary shares subject to possible redemption reflected on the balance sheet as of March 31, 2022 and December 31, 2021 is reconciled in the following table: Gross Proceeds from IPO $ 129,662,500 Less: Proceeds allocated to Public Warrants (3,493,159 ) Class A ordinary shares issuance costs (9,678,128 ) Plus: Remeasurement of carrying value to redemption value 13,178,196 Interest income 41,453 Class A ordinary shares subject to possible redemption $ 129,710,862
Summary of Earnings Per Share, Basic and Diluted	As a result, diluted loss per share is the same as basic loss per share for the period presented For the three months ended March 31, 2022 Class A Class B Basic and diluted net loss per share: Numerator: Allocation of net loss $ (322,826 ) $ (80,706 ) Denominator: Weighted-average shares outstanding including ordinary shares subject to redemption 12,650,000 3,162,500 Basic and diluted net loss per share $ (0.03 ) $ (0.03 )

Organization, Business Operat_2

Organization, Business Operation and Liquidity - Additional Information (Details) - USD ($)	Dec. 15, 2021	Dec. 14, 2021	Mar. 31, 2022	Dec. 31, 2021	Dec. 09, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Entity Incorporation Date Of Incorporation			Aug. 9, 2021
Proceeds from private placement of warrants			$ 3,493,159
Offering costs		$ 5,793,160	5,793,160
Underwriting commissions		1,800,000	1,800,000
Deferred underwriting commissions		3,150,000	3,150,000
Other Offering Costs		843,160	843,160
Cash			$ 909,562,000,000
Post-transaction ownership percentage of the target entity			50.00%
Investment of cash in Trust Account	$ 129,662,500	113,492,500	$ 129,662,500
Additional Deposit In advance From Related Party Deposited In Restricted Investments		742,500
Term of restricted investments	185 days		185 days
Percentage of public shares to be redeemed in case does not complete initial business combination within combination period			100.00%
Percentage of dutch dividend withholding tax			15.00%
Redemption Value Per Share			$ 10.25
Minimum netorth needed to consummate business combination			$ 5,000,001
Threshold period from the closing of public offering to consummate business combination as per amended and restated and restated articles of association			18 months
Threshold Period From The Closing Of The Public Offering Extends The Period Of Time To Consummate A Business Combination			24 months
Expenses payable on liquidation			$ 100,000
Period To complete business combination from closing of the Initial Public Offering			18 days
Payments to acquire restricted investment for each additional three month period			$ 1,265,000
Payments to acquire restricted investment for each additional three month period, Per share			$ 0.10
Minimum Per Share Amount To Be Maintained In The Trust Account			10.25
Payments To Acquire Restricted Investments Per Unit	$ 10.25		$ 10.25
Working Capital			$ 907,449,000,000
Sponsor [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock Issued During Period, Value, Issued for Services		25,000
Debt Instrument, Face Amount		$ 500,000
Minimum [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Fair market value as percentage of net assets held in trust account included in initial business combination			80.00%
Private Placement Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights warrants issued during the period		4,700,000
Class of warrants or rights warrants issued issue price per warrant		$ 1.50
Proceeds from private placement of warrants		$ 7,792,500
Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock par or stated value per share			$ 0.0001	$ 0.0001
IPO [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Investment of cash in Trust Account		$ 11,000,000
IPO [Member] | Public Warrants [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of shares issued upon exercise of warrant		1
Exercise price of warrant		$ 11.50
IPO [Member] | Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues		11,000,000
Shares issued price per share	$ 10	$ 10
Number of shares included in Unit		1
Proceeds from issuance initial public offering		$ 126,500,000
Over-Allotment Option [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Underwriting commissions		2,130,000	$ 2,130,000
Deferred underwriting commissions		3,727,500	3,727,500
Other Offering Costs		843,160	843,160
Additional transaction costs		907,500	907,500
Aggregate Transaction Costs		6,700,660	6,700,660
Cash			$ 1,641,236
Investment of cash in Trust Account		$ 10.25
Cash deposited in Trust Account per Unit		$ 129,662,500
Over-Allotment Option [Member] | Founder Shares [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common Stock, Other Shares, Outstanding			412,500		412,500
Over-Allotment Option [Member] | Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues		12,650,000
Over-Allotment Option [Member] | Common Class A [Member] | Underwriting Agreement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common Stock, Shares Subscribed but Unissued		1,650,000
Public Offering And Overallotment [Member] | Common Class A [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Stock issued during period shares new issues				12,650,000
Public Offering And Overallotment [Member] | Common Class A [Member] | Underwriting Agreement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Proceeds from issuance initial public offering	$ 16,500,000
Common Stock, Shares Subscribed but Unissued	1,650,000
Private Placement Warrants and overallotment [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Class of warrants or rights warrants issued during the period				5,195,000
Class Of Warrants Or Rights Issued During Period Warrants	495,000
Proceeds from Issuance of Private Placement	$ 742,500
IPO And Private Placement [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Investment of cash in Trust Account		$ 113,492,500
Advance From The Sponsor Deposited In Trust Account		$ 742,500	$ 16,170,000
Payments To Acquire Restricted Investments Per Unit		$ 10.25

Significant Accounting Polici_4

Significant Accounting Policies - Additional Information (Details) - USD ($)	Dec. 14, 2021	Mar. 31, 2022	Dec. 31, 2021
Accounting Policies [Line Items]
Cash equivalents at carrying value		$ 0	$ 0
Offering costs	$ 5,793,160	5,793,160
Underwriting commissions	1,800,000	1,800,000
Deferred underwriting commissions	3,150,000	3,150,000
Other Offering Costs	843,160	843,160
Dilutive securities			0
Cash insrued with federal deposit insurance corporation		250,000
Cash [Member]
Accounting Policies [Line Items]
Assets, Fair Value Disclosure			$ 1,485
US Treasury Securities [Member]
Accounting Policies [Line Items]
Assets, Fair Value Disclosure			$ 129,667,924
Over-Allotment Option [Member]
Accounting Policies [Line Items]
Underwriting commissions	2,130,000	2,130,000
Deferred underwriting commissions	3,727,500	3,727,500
Other Offering Costs	843,160	843,160
Additional transaction costs	907,500	907,500
Aggregate Transaction Costs	$ 6,700,660	$ 6,700,660
Common Class A [Member]
Accounting Policies [Line Items]
Number of Ordinary shares subject to possible redemptions		12,650,000	12,650,000

Significant Accounting Polici_5

Significant Accounting Policies - Summary of Debt Securities, Held-to-maturity (Detail) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Schedule of Held-to-maturity Securities [Line Items]
Carrying Value as of December 30, 2021	$ 129,710,862	$ 129,669,409
Gross Unrealized Losses	(79,253)	(2,770)
Fair Value, Inputs, Level 1 [Member]
Schedule of Held-to-maturity Securities [Line Items]
Quoted Prices in Active Markets (Level 1)	129,631,608	129,665,154
US Treasury Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Carrying Value as of December 30, 2021	129,709,377	129,667,924
Gross Unrealized Losses	(79,253)	(2,770)
US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Schedule of Held-to-maturity Securities [Line Items]
Quoted Prices in Active Markets (Level 1)	129,630,124	129,665,154
Cash [Member]
Schedule of Held-to-maturity Securities [Line Items]
Carrying Value as of December 30, 2021	1,485	1,485
Gross Unrealized Losses	0	0
Cash [Member] | Fair Value, Inputs, Level 1 [Member]
Schedule of Held-to-maturity Securities [Line Items]
Quoted Prices in Active Markets (Level 1)	$ 1,485	$ 0

Significant Accounting Polici_6

Significant Accounting Policies - Summary of Class A Ordinary Shares Subject to possible Redemption (Detail)	3 Months Ended
	Mar. 31, 2022USD ($)
Redeemable Noncontrolling Interest [Line Items]
Proceeds allocated to Public Warrants	$ 3,493,159
Class A ordinary shares issuance costs	9,678,128
Remeasurement of carrying value to redemption value	13,178,196
Interest income	41,453
Class A ordinary shares subject to possible redemption	129,710,862
Common Class A [Member] | Common Stock [Member]
Redeemable Noncontrolling Interest [Line Items]
Gross Proceeds from IPO	$ 129,662,500

Significant Accounting Polici_7

Significant Accounting Policies - Summary of Earnings Per Share, Basic and Diluted (Detail)	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Common Class A [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Allocation of net loss | $	$ (322,826)
Weighted-average shares outstanding including ordinary shares subject to redemption | shares	12,650,000
Basic and diluted net loss per share | $ / shares	$ (0.03)
Common Class B [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Allocation of net loss | $	$ (80,706)
Weighted-average shares outstanding including ordinary shares subject to redemption | shares	3,162,500
Basic and diluted net loss per share | $ / shares	$ (0.03)

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details) - USD ($)	Dec. 15, 2021	Dec. 14, 2021	Mar. 31, 2022	Dec. 31, 2021
Disclosure Of Initial Public Offering [Line Items]
Common stock, Conversion basis				one-to-one
Payments to acquire restricted investment	$ 129,662,500	$ 113,492,500	$ 129,662,500
Payments to acquire restricted investment, Per unit	$ 10.25		$ 10.25
Term of restricted investments	185 days		185 days
IPO [Member]
Disclosure Of Initial Public Offering [Line Items]
Payments to acquire restricted investment		11,000,000
IPO And Private Placement [Member]
Disclosure Of Initial Public Offering [Line Items]
Payments to acquire restricted investment		$ 113,492,500
Payments to acquire restricted investment, Per unit		$ 10.25
Advance from the sponsor deposited in trust account		$ 742,500	$ 16,170,000
Common Class A [Member]
Disclosure Of Initial Public Offering [Line Items]
Proceeds from issuance initial public offering and over allotment option, Gross	$ 126,500,000
Common Class A [Member] | Public Warrant [Member]
Disclosure Of Initial Public Offering [Line Items]
Class of warrant or right, Exercise price of warrants or rights		$ 11.50	$ 11.50
Common Class A [Member] | IPO [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period, Shares		11,000,000
Shares issued, Price per share	$ 10	$ 10
Common stock, Conversion basis		consists of one Class A ordinary share and one-third of one redeemable warrant.
Common Class A [Member] | IPO [Member] | Public Warrant [Member]
Disclosure Of Initial Public Offering [Line Items]
Class of warrant or right, Exercise price of warrants or rights		$ 11.50
Common Class A [Member] | IPO And Over Allotment Option [Member]
Disclosure Of Initial Public Offering [Line Items]
Stock issued during period, Shares	12,650,000

Private Placement - Additional

Private Placement - Additional Information (Details)	Dec. 15, 2021USD ($)shares	Mar. 31, 2022USD ($)d	Dec. 14, 2021$ / sharesshares
Private Placement [Line Items]
Proceeds from issuance of warrants | $		$ 3,493,159
Private Placement Warrant [Member]
Private Placement [Line Items]
Class of warrants or rights issued during period, Warrants	(5,195,000)
Private Placement Warrant [Member] | Minimum [Member]
Private Placement [Line Items]
Percentage of outstanding private placement warrant held by holders who vote in amending terms of warrant		50.00%
Private Placement Warrant [Member] | Private Placement [Member] | Sponsor [Member]
Private Placement [Line Items]
Class of warrants or rights issued during period, Warrants	4,700,000
Warrants issued, Price per warrant | $ / shares			$ 1.50
Private Placement Warrant [Member] | Common Class A [Member]
Private Placement [Line Items]
Lock up period | d		30
Private Placement Warrant [Member] | Common Class A [Member] | Sponsor [Member]
Private Placement [Line Items]
Class of warrant or right, Number of securities called by each warrant or right			1
Class of warrant or right, Exercise price of warrants or rights | $ / shares			$ 11.50
Private Placement Warrant [Member] | Private Placement And Over Allotment Option [Member] | Sponsor [Member]
Private Placement [Line Items]
Proceeds from issuance of warrants | $	$ 7,792,500

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Dec. 14, 2021	Dec. 09, 2021	Nov. 23, 2021	Aug. 12, 2021	Mar. 31, 2022	Dec. 31, 2021	Aug. 13, 2021
Business combination, Consummation period, Extension terms						two additional three-month periods
Extended period within which business combination shall be consummated					24 months
Payments to acquire restricted investment for each additional three month period					$ 1,265,000
Debt Instrument, Repurchase Date						Dec. 31, 2021
Working Capital Loans [Member]
Debt Instrument, Convertible, Carrying Amount of Equity Component					$ 1,500,000
Debt Instrument, Convertible, Conversion Price					$ 1.50
Bank Overdrafts					$ 0	$ 0
Extension Loans [Member]
Debt Instrument, Convertible, Conversion Price					$ 1.50
Extension Loans [Member] | Inorder To Extend Consummation Period [Member]
Payments to acquire restricted investment for each additional three month period					$ 1,265,000
Payments to acquire restricted investment for each additional three month period, Per share					0.10%
Services Agreement [Member]
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party					$ 18,493
Founder shares [Member] | Over-Allotment Option [Member]
Common stock, other shares, outstanding		412,500			412,500
Common shares subject to forfeiture						0
Forbion European Sponsor LLP [Member]
Stock issued during period, Value, Issued for services				$ 25,000
Shares Issued, Price Per Share				$ 0.009
Common Stock, Par or Stated Value Per Share				$ 0.0001
Debt Instrument, Face Amount				$ 500,000
Sponsor [Member]
Stock issued during period, Value, Issued for services	$ 25,000
Debt Instrument, Face Amount	$ 500,000
Sponsor [Member] | Office Space Secretarial And Administrative Services [Member]
Related party transaction, Amounts of transaction					$ 10,000
Sponsor [Member] | Salary [Member]
Related party transaction, Amounts of transaction					25,000
Sponsor [Member] | Administrative Services Agreement. [Member]
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party					30,000
Accrued in Administrative Fee Payable TO Related Party					37,097	$ 7,097
Sponsor [Member] | Services Agreement [Member]
Accrued In Comepnsation Expense To Related Party					22,192	3,699
Sponsor [Member] | Promissory Note [Member]
Due to related party					$ 0	$ 0
Common Class B [Member]
Common Stock, Par or Stated Value Per Share					$ 0.0001	$ 0.0001
Common stock, other shares, outstanding							375,000
Common Class B [Member] | Founder shares [Member]
Common stock, other shares, outstanding		412,500
Common Class B [Member] | Forbion European Sponsor LLP [Member]
Stock issued during period, Shares, Issued for services				2,875,000
Common Class B [Member] | Sponsor [Member]
Stock issued during period, Shares, Issued for services		287,500
Common Class B [Member] | Sponsor [Member] | Transfer Between Forbion European Sponsor LLP And Sponsor [Member]
Stock issued during period, Value, Issued for services			$ 25,000
Shares Issued, Price Per Share			$ 0.009
Stock issued during period, Shares, Issued for services			2,875,000

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Details)	Mar. 31, 2022USD ($)yrDay$ / sharesshares	Dec. 15, 2021USD ($)	Dec. 14, 2021USD ($)shares	Mar. 31, 2022USD ($)dDay$ / sharesshares
Underwriting commission, Per unit			0.20%
Payments for underwriting expense			$ 1,800,000
Deferred legal fees	$ 125,000			$ 125,000
Restriction On Transfer Of Founder Shares [Member] | Share Price Equals Or Exceeds Twelve USD [Member]
Number of trading days determining share price				20 days
Number of consecutive trading days determining share price				30 days
Threshold number of trading days determining share price				150 days
Founder Shares [Member] | Restriction On Transfer Of Founder Shares [Member]
Lock up period | yr	1
Common Class A [Member] | Restriction On Transfer Of Founder Shares [Member] | Share Price Equals Or Exceeds Twelve USD [Member]
Share price | $ / shares	$ 12			$ 12
Registration And Shareholder Rights Agreement [Member]
Number of demands that can be made | Day	3			3
Number of individuals for appointment to the board of directors nominated by sponsor | Day	3			3
Registration And Shareholder Rights Agreement [Member] | Common Class A [Member] | Private Placement Warrant [Member]
Lock up period | d				30
Underwriting Agreement [Member] | Over-Allotment Option [Member]
Payments for underwriting expense		$ 330,000
Deferred compensation liability, Noncurrent		577,500
Underwriting Agreement [Member] | IPO [Member]
Deferred compensation liability, Noncurrent			$ 3,150,000
Underwriting Agreement [Member] | IPO And Over Allotment Option [Member]
Payments for underwriting expense		2,130,000
Deferred compensation liability, Noncurrent		$ 3,727,500
Underwriting Agreement [Member] | Common Class A [Member] | Over-Allotment Option [Member]
Option vesting period		45 days
Common stock, shares subscribed but unissued | shares			1,650,000
Forward Purchase Agreements [Member] | FPA Purchaser [Member]
Number of agreements | Day	2			2
Forward Purchase Agreements [Member] | Common Class A [Member] | Firm Forward Purchase Shares [Member] | Private Placement [Member] | FPA Purchaser [Member]
Share price | $ / shares	$ 10			$ 10
Common stock, shares subscribed but unissued | shares	1,000,000			1,000,000
Common stock, value, subscriptions	$ 10,000,000			$ 10,000,000
Forward Purchase Agreements [Member] | Common Class A [Member] | Additional Forward Purchase Shares [Member] | Private Placement [Member] | FPA Purchaser [Member]
Share price | $ / shares	$ 10			$ 10
Common stock, shares subscribed but unissued | shares	1,000,000			1,000,000
Common stock, value, subscriptions	$ 10,000,000			$ 10,000,000

Shareholders' Deficit- Addition

Shareholders' Deficit- Additional Information (Details)	Mar. 31, 2022Classes$ / sharesshares	Dec. 14, 2021$ / sharesshares	Mar. 31, 2022Classes$ / sharesshares	Dec. 31, 2021$ / sharesshares	Dec. 09, 2021shares	Aug. 13, 2021USD ($)shares
Preferred stock par or stated value per share | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000		5,000,000	5,000,000
Preferred stock shares issued	0		0	0
Preferred stock shares outstanding	0		0	0
Board of directors, Service term				3 years
Number of class of directors being appointed in each year | Classes	1		1
Common stock, threshold percentage on conversion of shares	20.00%		20.00%
Common stock, Conversion basis				one-to-one
Number of trading days determining volume weighted average trading price of common stock				20 days
Number of days after consummation of business combination within which securities registration shall be effective	60 days		60 days
Number Of Days Of Average Closing Price determining Fair Market Value			10 days
Share Price Equals Or Exceeds Eighteen USD [Member]
Number of consecutive trading days determining share price				30 days
Public Warrant [Member]
Period after which the warrants are exercisable			30 days
Warrants and rights outstanding, Term	5 years		5 years
Class of warrant or right, Redemption price per warrant	0.01		0.01
Minimum notice of redemption period			30 days	30 days
Minimum [Member]
Percentage holding of common stock eligible for voting of directors	50.00%		50.00%
Common Class A [Member]
Common stock par or stated value per share | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000		500,000,000	500,000,000
Common stock, Shares, Outstanding	0		0	0
Temporary Equity, Shares Outstanding	12,650,000		12,650,000	12,650,000
Common Class A [Member] | Public Warrant [Member]
Class of warrant or right, Exercise price of warrants or rights | $ / shares	$ 11.50	$ 11.50	$ 11.50
Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total			60.00%
Common Class A [Member] | Public Warrant [Member] | Volume Weighted Average Trading Price Below Nine Point Twenty USD [Member]
Number of trading days determining volume weighted average trading price of common stock			20 days
Volume weighted average trading price of common stock			9.20
Class of Warrants Exercise Price Adjustment Percentage			115.00%
Common Class A [Member] | Public Warrant [Member] | Share Price Less Than Nine Point Twenty USD [Member]
Share price | $ / shares	$ 9.20		$ 9.20
Common Class A [Member] | Public Warrant [Member] | Share Price At Eighteen USD [Member]
Class of Warrants Exercise Price Adjustment Percentage			180.00%
Redemption trigger price per share	18		18
Common Class A [Member] | Public Warrant [Member] | Share Price Below Eighteen USD [Member]
Redemption trigger price per share	18		18
Common Class A [Member] | IPO [Member]
Common stock, Conversion basis		consists of one Class A ordinary share and one-third of one redeemable warrant.
Common Class A [Member] | IPO [Member] | Public Warrant [Member]
Class of warrant or right, Number of securities called by each warrant or right		1
Class of warrant or right, Exercise price of warrants or rights | $ / shares		$ 11.50
Common Class B [Member]
Common stock par or stated value per share | $ / shares	$ 0.0001		$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000		50,000,000	50,000,000
Common stock, Shares, Issued	3,162,500		3,162,500	3,162,500		2,875,000
Common stock, Shares, Outstanding	3,162,500		3,162,500	3,162,500		2,875,000
Common stock, Voting rights				one
Common stock, other shares, outstanding						375,000
Common stock, Other value, Outstanding | $						$ 0
Percentage of ownership held by initial shareholders after the Public Offer	20.00%		20.00%
Common Class B [Member] | Stock Dividend For Each Outstanding Share [Member]
Stock dividend, Per share			1.1
Common Class B [Member] | Founder Shares [Member]
Common stock, Shares, Outstanding					3,162,500
Common stock, other shares, outstanding					412,500